The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,910.00
Bid: 1,890.00
Ask: 1,910.00
Change: 20.00 (1.06%)
Spread: 20.00 (1.058%)
Open: 1,910.00
High: 1,910.00
Low: 1,890.00
Prev. Close: 1,890.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement to 11 December 2023

12 Dec 2023 07:00

RNS Number : 3926W
S & U PLC
12 December 2023
 

 

 

12 December 2023

 

S&U plc

("S&U" or "the Group")

 

TRADING STATEMENT

 

 

S&U, the specialist motor and property financier, today announces its trading update for the period from 1 August 2023 to 11 December 2023.

 

Following a very good first half, S&U continues to make steady, if more cautious, progress despite the "current economic, tax and regulatory burdens weighing on business" we reported at half year. Thus, Group net receivables now stand at £446 million (December 2022: £404 million) against £417 million at half year. Net receivables in Advantage, our motor finance business, are up £14 million in the period and £31 million on a year ago and stand at £327 million.

 

At Aspen, our Property Bridging lender, the net receivables are up £15 million in the period and £11 million on a year ago and stand at £119 million. These levels of activity and payment of the interim dividend have seen Group borrowing increase from £184 million at half year to £209 million now. This compares with £180 million a year ago and with Group committed facilities of £280 million.

 

Nevertheless, caution is necessary. Those burdens weighing on business are reflected in a lack of consumer confidence, cost-of-living pressures, persistently higher rates of interest, and a new raft of regulation, all of which inevitably affect profitability.

 

Further out, an anaemic outlook for growth in the UK, recently predicted by both the Office for Budget Responsibility and by the Governor of the Bank of England, combined with restrained growth in household expenditure over the next two years, make S&U's focus on working with our customers, credit quality and appropriate forbearance more essential than ever before. The volume of consumer finance used-car market transactions fell by 5% in the year to October 2023 according to the Finance and Leasing Association ("FLA"), whilst prices in the housing market remain subdued and, in many areas, actually in retreat. Hence, whilst we remain ambitious and optimistic, it would be unwise to plan for major growth until these trends have stabilised and economic prospects improved.

 

Advantage Motor Finance

 

Although transaction numbers have picked up well in the period, particularly in the higher tiers of customer quality which now make up 45% of new business, collection rates have felt the impact of the economic pressures mentioned earlier and live collections in the period were 91% of due (H1 23: 94%).

 

However, the number of bad debts and voluntary terminations in the period continued below budget, as it was in the first half year. Much of this has resulted from Advantage's long experience in adapting to customer circumstances offset by higher living costs and the need to codify and adapt to the requirements of the FCA's Consumer Duty introduced at half year.

 

This Duty forms part of a regulatory regime, encompassing forbearance, affordability and customer vulnerability, which for S&U stretches back over 50 years to our obligations under the Consumer Credit Act. More recently, these have been supplemented by a significant influx of consumer regulation from the Financial Conduct Authority as set out in its Principles for Business, Consumer Credit Source Book, its "Dear CEO" letters, the Borrowers in Financial Difficulty review, its Tailored Support Guidance•.and now by the Consumer Duty. As a consequence, attempting to reconcile and interpret the policy, process and operational requirements of these dictates has now become a major, often subjective and expensive process.

 

Following the FCA's special focus on Borrowers in Financial Difficulty (BiFD) in non-prime motor finance, the "review of Advantage's, collecting processes, procedures and policies" we noted at half year, has developed into a more formal interaction with the FCA. Along with many other lenders in our market segment, Advantage has appointed a Skilled Person. They are tasked, where necessary, to advise and guide Advantage in delivering, these regulatory requirements. This may be a lengthy and costly process, but it should prove valuable in providing assurance on our longstanding methods of serving our customers, and ensuring, that our products continue to meet their differing needs. These methods have been validated by Advantage's excellent record with the Financial Ombudsman Service which at an uphold rate of just 15% is, by some margin, the best in the motor finance industry.

 

This will provide both challenges and opportunities and, in paying tribute to the professionalism, patience and fortitude of our people at Advantage and to the leadership of Graham Wheeler, our retiring CEO, it gives me the opportunity to welcome his successor, Karl Werner, at an important and ultimately rewarding time.

 

Aspen Property Bridging Finance

Whatever the current headwinds in the U.K.'s residential property market, Aspen, our dynamic bridging lender, continues to make solid progress. Although, compared to the same period last year, increased interest costs which inherently take time to reflect in the pricing of the book, have put a break on recent profit growth, the outlook for interest rates and bridging transactions has improved in the period.

 

Collections in the period have continued to perform well and the number and value of extended or technically defaulted loans is 16, similar to the 15 we reported at the half year. Repayments in the past four months are an encouraging 20% above budget. At present around 55% of business is conducted in London and the South-east where refurbishment and tenant demand remains strong.

 

Recent trends on prospective business are also encouraging. The Aspen pipeline of new cases is at a record level and 30% above budget. Overall, Aspen is sensibly and steadily fulfilling the potential we foresaw at its founding seven years ago.

 

Funding

 

Group committed facilities of £280 million, against current borrowing of £209 million, comfortably allow for the cautious and sustainable growth we anticipate for S&U over the next year.

 

 

 

 

 

 

Outlook

 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U chairman, said:

 

"It would be foolish to underestimate the obstacles all businesses face in times of feeble growth, pressures on the consumer, high taxation and inflation, and regulatory changes and political uncertainty. Fortunately, this cocktail of challenges will be met with S&U's long-standing experience, ingenuity, expertise, decency and sheer hard work, allowing the Group to emerge as successful and as strong as ever."

 

 

 

For further information, please contact:

 

 

Enquiries

Anthony Coombs

 

S&U plc

c/o SEC Newgate

 

Financial Public Relations

Bob Huxford, Molly Gretton, Harry Handyside

 

SEC Newgate

020 7653 9848

Broker

Andrew Buchanan, Adrian Trimmings, Sam Milford

 

Peel Hunt LLP

020 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLBDDLUBDGXB
Date   Source Headline
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.